* All times are based on Europe/Athens EET.
9:00 AM
Europe/Athens
2 parallel sessions10:30 AM
Europe/Athens
Recombinant proteins and MAB development technologies
Discovery, engineering and development of recombinant proteins and monoclonal antibodies to target specific molecular pathways, offering treatments for diseases, including cancer, autoimmune and metabolic disorders.
12:15 PM
Europe/Athens
Recombinant proteins and MAB development technologies
Discovery, engineering and development of recombinant proteins and monoclonal antibodies to target specific molecular pathways, offering treatments for diseases, including cancer, autoimmune and metabolic disorders.
1:30 PM
Europe/Athens
2 parallel sessions2:30 PM
Europe/Athens
Gene editing technologies and applications in medicine
Discovery and engineering of effectors and their delivery approaches for the development of gene editing technologies that enable targeted modifications to DNA/RNA sequences and offer potential for treatment of genetic disorders and personalized medicine approaches.
4:45 PM
Europe/Athens
Gene editing technologies and applications in medicine
Discovery and engineering of effectors and their delivery approaches for the development of gene editing technologies that enable targeted modifications to DNA/RNA sequences and offer potential for treatment of genetic disorders and personalized medicine approaches.